T

he Trump administration may not support importing medicines from Canada, but that’s not stopping lawmakers in Vermont, who endorsed a bill that would make the state the first in the nation to designate wholesalers to buy drugs from across the border.

The bill, which was passed last week by both the Vermont House and Senate, is now before Gov. Phil Scott, who has so far not indicated whether he will sign the legislation into law but has until this week to decide. We asked his office for comment and will pass along any reply.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Per Vermont state senator Claire Ayer, setting up a track-and-trace system for #drugs imported from Canada will be “no biggie?” HAHAHAHA! I guess VT hasn’t heard about the super-simple Drug Supply Chain Security Act (DSCSA)? Yikes

    • Or, why have all oher state importation plans failed? Ya know — “no biggie.” Oy vey.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy